Arcturus Therapeutics Holdings Inc (ARCT NASDAQ) stock market data APIs
$11.0744
0.67(6%)
as of October 30, 2026
Try our APIs with
free plan!
Arcturus Therapeutics Holdings Inc Financial Data Overview
Price chart is built with
Anychart
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
Prev. Close
11.0744
Open
11.7442
High
12.0353
Low
10.6183
52 wk Range
5.5-17.96
Market Cap
314 M
Shares Outstanding
28 423 K
Revenue
29 368 K
Beta
2.483
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Arcturus Therapeutics Holdings Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Arcturus Therapeutics Holdings Inc data using free add-ons & libraries
Get Arcturus Therapeutics Holdings Inc Fundamental Data
Arcturus Therapeutics Holdings Inc Fundamental data includes:
- Net Revenue: 29 368 K
- EBITDA: -99 548 000
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Arcturus Therapeutics Holdings Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: -0.6
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Arcturus Therapeutics Holdings Inc News
New
Are Medical Stocks Lagging Agilon Health (AGL) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Agilon Health (AGL) is a stock that can certainly grab the attention of many investo...
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csect...
4 RNA Therapeutics Stocks Leading the Next Wave of Innovation
RNA therapeutics are medicines that use RNA molecules to influence gene expression or protein production. Unlike many conventional drugs that act directly on proteins, RNA medicines can intervene earl...
Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency
[Stethoscope and white card with RARE DISEASES text on blue background.] Zolak/iStock via Getty Images Arcturus Therapeutics (ARCT [https://seekingalpha.com/symbol/ARCT]) said that interim phase 2 re...
Get Arcturus Therapeutics Holdings Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.